Novel Coronavirus (SARS-CoV-2/COVID-19)
The Centers for Medicare & Medicaid Services (CMS) last night issued updated guidance on providing essential non-COVID-19 care to patients without symptoms of COVID-19 in regions with low and stable incidence of the virus. This is part of Phase 1 in the Administration’s Guidelines for Opening…
COVID-19 has been a devastating experience everywhere, but in small, rural hospitals and their communities, the impact is particularly intense.
Statement on CMS guidance on elective procedures from AHA President and CEO Rick Pollack.
As you continue discussions with other congressional leaders and the Administration on the next COVID-19 package, we urge you to continue to prioritize additional support to ensure hospitals and health systems have what they need to protect their patients, communities and caregivers.
We urge the President to prioritize additional support to ensure hospitals and health systems continue to have what they need to protect their patients, communities and caregivers. Many hospitals are in dire circumstances as they face the biggest financial crisis in history.
The Food and Drug Administration encouraged those who have recovered from COVID-19 to donate plasma for the creation of convalescent plasma, an antibody-rich investigational therapy that may help others fight the disease.
The Food and Drug Administration issued guidance expanding the use of telethermographic systems for triage use during the public health crisis.
The Centers for Disease Control and Prevention has collated in one location training materials for health care professionals during the COVID-19 emergency, including webinars, videos and online courses.
The FEMA Healthcare Resilience Task Force has released a COVID-19 Hospital Resource Package, which offers tools to help hospitals prepare for and respond to the pandemic.
The Food and Drug Administration announced that spun synthetic swabs made from materials like polyester can be used for test patients for COVID-19.